Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Use of oral anticoagulants in patients with atrial fibrillation and renal
dysfunctionUse of oral anticoagulants in patients with atrial fibrillation and renal
dysfunction, Published online: 26 March 2018; doi:10.1038/nrneph.2018.19Renal dysfunction and atrial fibrillation (AF) share common risk factors and often coexist. Here, the authors discuss the risks and benefits of use of vitamin K antagonists (VKAs) and non-VKA oral anticoagulants for thromboprophylaxis in patients with coexistent AF and renal dysfunction.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tatjana S. Potpara Charles J. Ferro Gregory Y. H. Lip Source Type: research